While many AIs used to assist drug discovery are provided by big tech companies at a cost, a small US and China-based techbio ...
Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...